

Cover Story
Free
By Matthew Bin Han Ong
Last August, Stephen A. Chagares, a breast surgeon, made an announcement that startled some of his colleagues at New Jersey’s Monmouth Medical Center. At internal meetings and in a press release, Chagares declared that he would perform a robotic mastectomy—a new and relatively untested minimally invasive surgical procedure. According to the press release, his first patient, Yvonne Zucco, 56, was being treated for stage IIa breast cancer.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Trump’s tariffs on generic drugs are “another wrinkle in an already unstable system”
- NCAB asks for help from administration as NCI deals with deluge of grant applications
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Raja Flores says oncology is loose with staging jargon, and now “it’s confusing my patients.”













